Pharma Mar | PHM - Ebit

Aktienkurs
86.40
Täglich Wechseln
-1.15 -1.31%
Monatlich
8.47%
Jährlich
-2.81%
Q1 Prognose
80.84




Ebit Veränderung Datum
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Almirall EUR 30.23M 12.8M 2025-12
Avita Medical AUD -10.39M 1.72M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 28M 2025-09
Pharma Mar EUR 43.61M 47.57M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12